Regulations/Policies - Express Pharma

Critical to make a clear distinction between NSQ and Spurious Drugs: IPA

Industry hails Bio E3 policy as transformative for India’s biotech sector

Ministry of Science and Technology releases new BioE3 policy

Govt bans 156 FDCs with immediate effect

JP Nadda inaugurates First Policy Makers’ forum in New Delhi

Regulatory convergence is extremely important

Indian biotech start-ups: Need for pragmatic, pro-active, progressive regulatory milieu

DoP implements PLI scheme for pharmaceuticals with a financial outlay of Rs 15,000 cr

Navigating the IPR maze: India’s pharmaceutical challenge

Revised pharmacovigilance guidance for human vaccines open for public consultation